Diagnosis
Understanding Batten disease can be difficult due to its rarity. It is estimated that only two to four out of 100,000 children in the United States are affected by this condition. As a result, diagnosing Batten disease can be a challenge. Medical professionals rely on a combination of symptoms, medical history, and laboratory results to reach a diagnosis. In some cases, when the mutated gene is present in multiple family members, the diagnosis process can be expedited.
Advancements in Pharmacological Treatment and Research for Batton Disease
Although currently only one subtype of Batton disease has an approved treatment, extensive research is underway to discover more effective therapies. Encouraging laboratory findings have been reported, particularly in the context of enzyme replacement therapy. This approach has demonstrated positive outcomes in mouse and canine models of CLN2, successfully delaying symptom onset and extending the lifespan of affected subjects. Additionally, scientists are exploring the potential of immunomodulatory agents to suppress inflammation and degeneration in sheep affected by CLN6, as well as in mice with CLN1 and CLN3.